Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Neuraltus, University of Hawaii Initiate Phase 1b NP001 Study for Mild-to-Moderate Alzheimer's

americanpharmaceuticacreviewSeptember 14, 2017

Tag: Hawaii , 1b NP001 Study , Mild-to-Moderate Alzheimer's

PharmaSources Customer Service